Clinical Trial Update: Ipatasertib (GDC-0068) Study to Evaluate Formulation Change and Food Effect on Bioavailability in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study in healthy subjects to evaluate a formulation change and the effect of food on the bioavailability of ipatasertib (GDC-0068) sponsored by Genentec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• ipatasertib (ipatasertib)

Snippet

Sponsor: Genentech, Inc. | Conditions: Cancer | Phase 1 | Status: COMPLETED